How To Invest In ORIC Pharmaceuticals Inc Stock - ORIC Share Price Today & News | Stash

Invest in ORIC Pharmaceuticals Inc on Stash

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on improving patients' lives by overcoming resistance in cancer.

To buy fractional shares of ORIC Pharmaceuticals Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.

Ticker: ORIC

ORIC Pharmaceuticals Inc

$10.73

-1.92% (1W)

Jul ’26Jul ’26$11$11$12

1W1M1Y5Y

ORIC Performance Breakdown

Share Price
The last publicly stated price for one share of an investment, updated every approximately 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).

$10.73

Today's change
This is how much an investment's price has changed over the last day of active trading. For example, if an investment's price was $10 yesterday, and today it rose to $11, you'd see a 1 day change of 10%.

0.0%

Year to date change (YTD)
This is the performance of the investments since the start of the year, updated approximately every 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).

31.33%

Dividend yield
Some investments pay you profits or interest as you hold them. These payments are called dividends, and this value represents the dollar value as a percentage of the investment's share price.

0.0

Last dividend paid
The dollar value per share that was paid out to shareholders.

N/A

Last dividend pay date
The date shareholders were paid out for the last dividend issued.

N/A

About ORIC

ORIC Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on improving patients' lives by overcoming resistance in cancer. The Company is focused on developing a diverse pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its experience within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. Its lead product candidate is ORIC-101. The Company’s ORIC-101 is a potent and selective small-molecule antagonist of the glucocorticoid receptor (GR), which has been linked to resistance to multiple classes of cancer therapeutics across a variety of solid tumors. The Company’s second product candidate, ORIC-533, is an orally bioavailable, small-molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens. Its third product candidate, ORIC-944, is being developed for prostate cancer.

How to buy ORIC Pharmaceuticals Inc stock on Stash

  1. Enter the amount you'd like to invest in ORIC Pharmaceuticals Inc stock, then proceed to checkout.

    Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

  2. Set up your investment account in just a few minutes.

    Stash offers one subscription plan: The Stash Plan.

  3. Once you’ve finished your account, your ORIC Pharmaceuticals Inc shares will be added to your new portfolio.

    Once your market order of ORIC Pharmaceuticals Inc stock is complete, you'll officially be a shareholder of ORIC Pharmaceuticals Inc!